Editas Medicine
-$0.20 (-1.37%) Today
-$0.10 (-0.70%) As of 8:06 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.
About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
CEO
Gilmore O’Neill
Employees
264
Headquarters
Cambridge, Massachusetts
Founded
2013
EDIT Key Statistics
Market cap
984.98M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.01M
High today
$15.07
Low today
$13.95
Open price
$14.42
Volume
1.92M
52 Week high
$73.03
52 Week low
$9.59
Analyst ratings
41%
of 17 ratings
Buy
41.2%
Hold
41.2%
Sell
17.6%
EDIT Earnings
-$1.00
-$0.67
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, Pre-Market